Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity

European Heart Journal

Volumn 25, Issue 3, 2004, Pages 206-211

  Briguori, Carlo ^a,b   Colombo, Antonio ^b   Violante, Anna ^a   Balestrieri, Pasquale ^a   Manganelli, Fiore ^a   Elia, Pietro Paolo ^a   Golia, Bruno ^a   Lepore, Stefano ^a   Riviezzo, Guido ^a   Scarpato, Pierfranco ^a   Focaccio, Amelia ^a   Librera, Mariateresa ^a   Bonizzoni, Erminio ^c   Ricciardelli, Bruno ^a  

^a Clinica Mediterranea   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Complications; Contrast media; Kidney; Prevention

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; CREATININE; IOBITRIDOL; SODIUM CHLORIDE;

ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; BRONCHOSPASM; CENTRAL NERVOUS SYSTEM DISEASE; CHILL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMOPTYSIS; HUMAN; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEPHROTOXICITY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REHYDRATION; RESPIRATORY TRACT DISEASE; RHINORRHEA; TRANSLUMINAL CORONARY ANGIOPLASTY; VOMITING;

ACETYLCYSTEINE; AGED; CONTRAST MEDIA; DRUG ADMINISTRATION SCHEDULE; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; IOHEXOL; KIDNEY DISEASES; MALE; PROSPECTIVE STUDIES;

EID: 10744233453     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.11.016     Document Type: Article

References (33)

1. Parfrey PS, Griffiths SM, Barrett BJ et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989;320:143-9.
2. Chertow GM, Christiansen CL, Cleary DP. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995;155:1505-11.
3. Gruberg L, Mehran R, Dangas G et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Cathet Cardiovasc Intervent 2001;52:409-16.
4. McCullough PA, Wolyn R, Rocher LL et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75.
5. Solomon R, Werner C, Mann D et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
6. Cigarroa RG, Lange RA, Williams RH et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649-52.
7. Schwab SJ, Hlatky MA, Pieper KS et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989;320:149-53.
8. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-8.
9. Steinberg EP, Moore RD, Powe NR et al. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl Med J 1992;326:425-30.
10. Tepel M, Van der Giet M, Schwarzfeld C et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
11. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002;89:356-8.
12. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002;40:1383-8.
13. Kay J, Chow WH, Chan TM et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003;289:553-8.
14. Briguori C, Manganelli F, Scarpato P et al. Acetylcysteine and contrast-agent associated nephrotoxicity. J Am Coll Cardiol 2002;40:298-303.
15. Allaqaband S, Tumulud R, Malik AM et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and seline for prevention of radiocontrast-induced nephropathy. Cathet Cardiovasc Interv 2002;57:279-83.
16. Durham DJ, Caputo C, Dokko J et al. A randomized controlled trial on N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 2002;62:2202-7.
17. DiMari J, Megyesi J, Udvarhelyi N et al. N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 1997;272:F292-8.
18. Tariq M, Morais C, Sobki A et al. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 1999;14:923-9.
19. Cotgrease I, Moldeus P, Schuppe I. The metabolism of N-acetylcysteine by human endothelial cells. Biochem Pharmacol 1991;42:13-6.
20. Cockcroft DW, Gault MH. Prediction of creatine clearance from serum creatine. Nephron 1976;16:31-41.
21. Freeman RV, O'Donnell M, Share D et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002;90:1068-73.
22. Goodman and Gilman. The Pharmacological Basis of Therapeutics. Seventh edition. MacMillan Publishing Company, 1995.
23. Hou SH, Bushinsky DA, Wish JB et al. Hospital acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8.
24. Berns AS. Nephrotoxicity of contrast media. Kidney Inter 1989;36:730-40.
25. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int 1992;41:1408-15.
26. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-63.
27. Bakris GL, Lass N, Gaber AO et al. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990;258:F115-20.
28. Baliga R, Ueda N, Walker PD et al. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997;29:465-77.
29. Andrews NP, Prasad A, Quyymi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001;37:117-23.
30. Mason RA, Arbeit LA, Giron F. Renal dysfunction after arteriography. JAMA 1985;253:1001-4.
31. Vliestre RE, Nunn CM, Naverte J et al. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 1996;32:1049-50.
32. Noto TJ, Johnson LE, Krone R et al. Cardiac catheterization 1990: a report of the registry of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn 1991;24:75-83.
33. Aspelin P, Aubry P, Frausson SG et al. Nephrotoxic effects in high-risk patients undergoing angioplasty. N Engl J Med 2003;348:491-9.